Literature DB >> 15287277

Longitudinal changes in health status using the chronic respiratory disease questionnaire and pulmonary function in patients with stable chronic obstructive pulmonary disease.

T Oga1, K Nishimura, M Tsukino, T Hajiro, S Sato, A Ikeda, C Hamadas, M Mishima.   

Abstract

Long-term changes in health status have been less evaluated in patients with chronic obstructive pulmonary disease (COPD), in comparison to the changes in forced expiratory volume in 1 s (FEV1). Accordingly, we examined the clinical course of health status as well as pulmonary function in COPD patients, and investigated the relationship between the change in health status and the change in pulmonary function in a 3-year longitudinal study involving 224 patients with COPD. Health status using the Chronic Respiratory Disease Questionnaire (CRQ) and pulmonary function were measured at baseline and every six months over three years. We used the random effects model for the slopes to estimate the longitudinal changes. A total of 147 patients completed the 3-year study. The dyspnoea, fatigue, and emotional function domains of the CRQ declined slowly but significantly over 3 years (p = 0.001, 0.003, and 0.004, respectively) with a mean decline rate of 0.08/year. This means that it would take about 6 years to reach the minimal important change of 0.5 on the CRQ. The mean decline in post-bronchodilator FEV1 was 60 ml/year. None of the changes in any of the domains of the CRQ were significantly correlated with the changes in pulmonary function. We have found that, in comparison to the decline in pulmonary function, health status evaluated by the CRQ declined significantly but very slowly in three of four domains over three years in patients with COPD. Furthermore, we have demonstrated that there was no significant relationship between the change in health status and the change in pulmonary function.

Entities:  

Mesh:

Year:  2004        PMID: 15287277     DOI: 10.1023/B:QURE.0000031345.56580.6a

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  29 in total

Review 1.  Health status measurement in chronic obstructive pulmonary disease.

Authors:  P W Jones
Journal:  Thorax       Date:  2001-11       Impact factor: 9.139

2.  Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial.

Authors:  P S Burge; P M Calverley; P W Jones; S Spencer; J A Anderson; T K Maslen
Journal:  BMJ       Date:  2000-05-13

3.  Health-related quality of life in patients under long-term oxygen therapy: a home-based descriptive study.

Authors:  J P Janssens; T Rochat; J G Frey; N Dousse; C Pichard; J M Tschopp
Journal:  Respir Med       Date:  1997-11       Impact factor: 3.415

4.  Health status deterioration in patients with chronic obstructive pulmonary disease.

Authors:  S Spencer; P M Calverley; P Sherwood Burge; P W Jones
Journal:  Am J Respir Crit Care Med       Date:  2001-01       Impact factor: 21.405

5.  A comparison of three disease-specific and two generic health-status measures to evaluate the outcome of pulmonary rehabilitation in COPD.

Authors:  S J Singh; S C Sodergren; M E Hyland; J Williams; M D Morgan
Journal:  Respir Med       Date:  2001-01       Impact factor: 3.415

6.  Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial.

Authors:  J Vestbo; T Sørensen; P Lange; A Brix; P Torre; K Viskum
Journal:  Lancet       Date:  1999-05-29       Impact factor: 79.321

7.  Random-effects models for longitudinal data.

Authors:  N M Laird; J H Ware
Journal:  Biometrics       Date:  1982-12       Impact factor: 2.571

8.  A measure of quality of life for clinical trials in chronic lung disease.

Authors:  G H Guyatt; L B Berman; M Townsend; S O Pugsley; L W Chambers
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

9.  Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease.

Authors:  T Hajiro; K Nishimura; M Tsukino; A Ikeda; H Koyama; T Izumi
Journal:  Am J Respir Crit Care Med       Date:  1998-03       Impact factor: 21.405

10.  Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.

Authors:  N R Anthonisen; J E Connett; J P Kiley; M D Altose; W C Bailey; A S Buist; W A Conway; P L Enright; R E Kanner; P O'Hara
Journal:  JAMA       Date:  1994-11-16       Impact factor: 56.272

View more
  9 in total

1.  Medium term effects of including manual therapy in a pulmonary rehabilitation program for chronic obstructive pulmonary disease (COPD): a randomized controlled pilot trial.

Authors:  Roger Mark Engel; Peter Gonski; Ken Beath; Subramanyam Vemulpad
Journal:  J Man Manip Ther       Date:  2016-05

2.  Fatigue in patients with COPD participating in a pulmonary rehabilitation program.

Authors:  Cindy J Wong; Donna Goodridge; Darcy D Marciniuk; Donna Rennie
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-10-05

Review 3.  New modalities of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease.

Authors:  Martijn A Spruit; Emiel F M Wouters
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

4.  Does one year change in quality of life predict the mortality in patients with chronic obstructive pulmonary disease?-Prospective cohort study.

Authors:  Yavuz Havlucu; Arzu Yorgancıoglu; Aysin Sakar Coskun; Pinar Celık
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

5.  Health status in the TORCH study of COPD: treatment efficacy and other determinants of change.

Authors:  Paul W Jones; Julie A Anderson; Peter Ma Calverley; Bartolome R Celli; Gary T Ferguson; Christine Jenkins; Julie C Yates; Jørgen Vestbo; Michael D Spencer
Journal:  Respir Res       Date:  2011-05-31

6.  Impaired health status and care dependency in patients with advanced COPD or chronic heart failure.

Authors:  Daisy J A Janssen; Frits M E Franssen; Emiel F M Wouters; Jos M G A Schols; Martijn A Spruit
Journal:  Qual Life Res       Date:  2011-03-27       Impact factor: 4.147

7.  Using individual growth model to analyze the change in quality of life from adolescence to adulthood.

Authors:  Henian Chen; Patricia Cohen
Journal:  Health Qual Life Outcomes       Date:  2006-02-21       Impact factor: 3.186

8.  Reliability of the Brazilian Portuguese version of the fatigue severity scale and its correlation with pulmonary function, dyspnea, and functional capacity in patients with COPD.

Authors:  Silvia Valderramas; Aquiles Assunção Camelier; Sinara Alves da Silva; Renata Mallmann; Hanna Karine de Paulo; Fernanda Warken Rosa
Journal:  J Bras Pneumol       Date:  2013 Jun-Aug       Impact factor: 2.624

9.  Health-related quality of life and chronic obstructive pulmonary disease in early stages - longitudinal results from the population-based KORA cohort in a working age population.

Authors:  Margarethe E Wacker; Matthias Hunger; Stefan Karrasch; Joachim Heinrich; Annette Peters; Holger Schulz; Rolf Holle
Journal:  BMC Pulm Med       Date:  2014-08-09       Impact factor: 3.317

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.